Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.45 USD | -3.92% | -7.20% | +44.12% |
04-23 | Capital One Starts Heron Therapeutics With Overweight Rating, $6 Price Target | MT |
03-21 | Heron Therapeutics, Inc. Announces Executive Changes, Effective March 29, 2024 | CI |
Sales 2024 * | 145M 11.6B | Sales 2025 * | 175M 14.02B | Capitalization | 368M 29.49B |
---|---|---|---|---|---|
Net income 2024 * | -32M -2.56B | Net income 2025 * | -9M -720M | EV / Sales 2024 * | 2.54 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 2.1 x |
P/E ratio 2024 * |
-11.5
x | P/E ratio 2025 * |
-38.7
x | Employees | 126 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 99.05% |
Latest transcript on Heron Therapeutics, Inc.
1 day | -3.92% | ||
1 week | -7.20% | ||
Current month | -11.55% | ||
1 month | -10.58% | ||
3 months | -1.61% | ||
6 months | +307.11% | ||
Current year | +44.12% |
Managers | Title | Age | Since |
---|---|---|---|
Craig Collard
CEO | Chief Executive Officer | 58 | 20/02/23 |
Ira Duarte
DFI | Director of Finance/CFO | 55 | 15/06/23 |
Chris Storgard
CTO | Chief Tech/Sci/R&D Officer | 58 | 31/10/18 |
Members of the board | Title | Age | Since |
---|---|---|---|
Craig Collard
CEO | Chief Executive Officer | 58 | 20/02/23 |
Susan Rodriguez
BRD | Director/Board Member | 60 | 19/09/21 |
Craig Johnson
BRD | Director/Board Member | 62 | 12/01/14 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.00% | 9 M€ | -.--% | - |
Date | Price | Change | Volume |
---|---|---|---|
26/04/24 | 2.45 | -3.92% | 2,311,863 |
25/04/24 | 2.55 | -3.77% | 2,197,081 |
24/04/24 | 2.65 | -5.36% | 2,169,539 |
23/04/24 | 2.8 | +8.11% | 6,563,663 |
22/04/24 | 2.59 | -1.89% | 2,089,310 |
Delayed Quote Nasdaq, April 26, 2024 at 09:00 pm
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+44.12% | 368M | |
+1.51% | 42.75B | |
+8.57% | 41.34B | |
+49.22% | 41.61B | |
-12.36% | 26.59B | |
+8.92% | 25.49B | |
-25.13% | 18.12B | |
+29.17% | 12.24B | |
-3.12% | 11.76B | |
+6.35% | 11B |
- Stock Market
- Equities
- HRTX Stock